AMARIN CORP PLC\UK Amortization of Other Deferred Charges
AMARIN CORP PLC\UK (AMRN) reported Amortization of Other Deferred Charges of $0 for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAmortizationOfDeferredCharges · last filed 2012-11-08
- 2012-09-30: Amortization of Other Deferred Charges 9 month $0.00.
- 2011-09-30: Amortization of Other Deferred Charges 9 month $1.00M.
| Period end | Amortization of Other Deferred Charges 9 month |
|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 |
| 2011-09-30 | $1.00M 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |